FDA keeps warning about the supplement kratom, but companies keep selling it

FDA has issued warnings to two additional companies selling the controversial supplement kratom. Chillin Mix Kratom, one of the companies, sells more than two pounds of powdered kratom for just $65, while the other, Mitra Distributing, sells kratom wholesale.

FDA has issued warnings to two additional companies selling the controversial supplement kratom. Chillin Mix Kratom, one of the companies, sells more than two pounds of powdered kratom for just $65, while the other, Mitra Distributing, sells kratom wholesale. Both illegally claim that their products can be used as a treatment or cure for opioid addiction and withdrawal symptoms, according to FDA's warning letters to them, which were made public on Tuesday. The agency determined earlier this year that kratom should not be used for any of those conditions, since there is no evidence that it is safe and effective; the regulator has also concluded that the supplement contains addictive opioids. FDA has warned about the product and safety concerns associated with it several times since last fall, including a statement earlier this year that 44 deaths had been associated with the product. "Simply, selling these unapproved kratom products with claims that they can treat opioid withdrawal and addiction and other serious medical conditions is a violation of federal law," FDA said in a Tuesday statement. "Yet despite our warnings and previous regulatory and enforcement actions, we continue to find marketers actively selling kratom with unsubstantiated claims."